Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Shares Sold by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. trimmed its stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 14.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,770 shares of the company’s stock after selling 636 shares during the quarter. Raymond James Financial Services Advisors Inc. owned approximately 0.10% of Invesco Pharmaceuticals ETF worth $287,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Modera Wealth Management LLC acquired a new position in shares of Invesco Pharmaceuticals ETF in the 3rd quarter worth $538,000. UBS Group AG grew its holdings in shares of Invesco Pharmaceuticals ETF by 132.2% in the 3rd quarter. UBS Group AG now owns 92,123 shares of the company’s stock worth $6,667,000 after acquiring an additional 52,455 shares during the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Invesco Pharmaceuticals ETF by 206.0% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 41,273 shares of the company’s stock worth $2,987,000 after acquiring an additional 27,786 shares during the last quarter. Horizon Bancorp Inc. IN acquired a new position in shares of Invesco Pharmaceuticals ETF in the 3rd quarter worth $59,000. Finally, Geneos Wealth Management Inc. grew its holdings in shares of Invesco Pharmaceuticals ETF by 613.3% in the 3rd quarter. Geneos Wealth Management Inc. now owns 1,070 shares of the company’s stock worth $77,000 after acquiring an additional 920 shares during the last quarter.

Invesco Pharmaceuticals ETF Stock Down 0.1 %

Shares of NYSEARCA PJP opened at $75.99 on Tuesday. Invesco Pharmaceuticals ETF has a 52-week low of $67.75 and a 52-week high of $80.65. The stock has a market capitalization of $266.71 million, a price-to-earnings ratio of 20.52 and a beta of 0.64. The stock’s fifty day simple moving average is $77.93 and its 200 day simple moving average is $74.91.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.